News
![Atara_bio](https://pharmaphorum.com/wp-content/uploads/2021/11/Atara_bio.jpg)
Atara closes on first approval of transplant complication th...
Atara Biotherapeutics' cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), according to the EMA's human med